Evidence map›Paper›PMID 38519891›Full record

SynthesisBMC public health2024

Systematic review of empiric studies on lockdowns, workplace closures, and other non-pharmaceutical interventions in non-healthcare workplaces during the initial year of the COVID-19 pandemic: benefits and selected unintended consequences.

Faruque Ahmed, Livvy Shafer, Pallavi Malla, Roderick Hopkins, Sarah Moreland, Nicole Zviedrite, Amra Uzicanin

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faruque AhmedDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA. fahmed@cdc.gov.
Livvy ShaferDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.
Pallavi MallaDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.
Roderick HopkinsDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.
Sarah MorelandDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.
Nicole ZviedriteDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.
Amra UzicaninDivision of Global Migration Health, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V18-2, Atlanta, GA, 30329-4027, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe conducted a systematic review aimed to evaluate the effects of non-pharmaceutical interventions within non-healthcare workplaces and community-level workplace closures and lockdowns on COVID-19 morbidity and mortality, selected mental disorders, and employment outcomes in workers or the general population.

methodsThe inclusion criteria included randomized controlled trials and non-randomized studies of interventions. The exclusion criteria included modeling studies. Electronic searches were conducted using MEDLINE, Embase, and other databases from January 1, 2020, through May 11, 2021. Risk of bias was assessed using the Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) tool. Meta-analysis and sign tests were performed.

resultsA total of 60 observational studies met the inclusion criteria. There were 40 studies on COVID-19 outcomes, 15 on anxiety and depression symptoms, and five on unemployment and labor force participation. There was a paucity of studies on physical distancing, physical barriers, and symptom and temperature screening within workplaces. The sign test indicated that lockdown reduced COVID-19 incidence or case growth rate (23 studies, p < 0.001), reproduction number (11 studies, p < 0.001), and COVID-19 mortality or death growth rate (seven studies, p < 0.05) in the general population. Lockdown did not have any effect on anxiety symptoms (pooled standardized mean difference = -0.02, 95% CI: -0.06, 0.02). Lockdown had a small effect on increasing depression symptoms (pooled standardized mean difference = 0.16, 95% CI: 0.10, 0.21), but publication bias could account for the observed effect. Lockdown increased unemployment (pooled mean difference = 4.48 percentage points, 95% CI: 1.79, 7.17) and decreased labor force participation (pooled mean difference = -2.46 percentage points, 95% CI: -3.16, -1.77). The risk of bias for most of the studies on COVID-19 or employment outcomes was moderate or serious. The risk of bias for the studies on anxiety or depression symptoms was serious or critical.

conclusionsEmpiric studies indicated that lockdown reduced the impact of COVID-19, but that it had notable unwanted effects. There is a pronounced paucity of studies on the effect of interventions within still-open workplaces. It is important for countries that implement lockdown in future pandemics to consider strategies to mitigate these unintended consequences. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration # CRD42020182660.

Indexed as

COVID-19WorkplaceCommunicable Disease ControlEmploymentHumansPandemicsQuarantineSARS-CoV-2AnxietyCommunity mitigationCOVID-19DepressionEmploymentLockdownNon-pharmaceuticalNovel coronavirusSocial distancingSystematic reviewWorkplace

Identifiers

PMID38519891
PMCPMC10960383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.